Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced ...

Models and simulations of design integrate computational representations of products, processes and systems with numerical experiments to predict performance, guide decision‐making and accelerate ...

Artificial intelligence (AI) has been revolutionizing much of early drug discovery, yet human clinical trials remain a bottleneck. Now some applications of the new technologies are bringing ...

Simulation models guide million-dollar inventory decisions, staffing patterns that affect patient care and investment strategies that manage pension funds. Yet many organizations still treat them as ...

Hybrid climate modeling has emerged as an effective way to reduce the computational costs associated with cloud-resolving models while retaining their accuracy. The approach retains physics-based ...

Modeling and simulation technology has become increasingly important to both the entertainment industry and the U.S. Department of Defense (DOD). In the entertainment industry, such technology lies at ...

ASDs are among the most powerful yet complex oral drug delivery systems, with performance influenced by factors such as food intake, gastric pH, formulation composition, and manufacturing processes.

Computational Chemistry is the study of complex chemical problems using a combination of computer simulations, chemistry theory and information science. Also called cheminformatics, this field enables ...

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...

Simulations Plus, Inc. SLP shares are trading lower on Wednesday as the company announced a collaboration with NVIDIA Corp NVDA, aimed at enhancing GPU-accelerated simulation and AI-assisted workflows ...

Icelandic audio startup Treble Technologies ehf today announced that it has raised $18 million in funding. Paladin Capital Group led the Series-A2 round. It was joined by returning backers KOMPAS VC, ...